| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |